[HTML][HTML] Treatment of Helicobacter pylori infection: current status and future concepts
JC Yang, CW Lu, CJ Lin - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) infection is highly associated with the occurrence of
gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric cancer, and …
gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric cancer, and …
[HTML][HTML] Treatment of Helicobacter pylori infection: Current and future insights
Helicobacter pylori (H. pylori) is an important major cause of peptic ulcer disease and gastric
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …
[HTML][HTML] Eradication of Helicobacter pylori infection: which regimen first?
A Federico, AG Gravina, A Miranda… - World journal of …, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is a well-known human pathogen that plays an essential role
in the pathogenesis of chronic gastritis, peptic ulcer disease, and gastric malignancies …
in the pathogenesis of chronic gastritis, peptic ulcer disease, and gastric malignancies …
[HTML][HTML] Treatment of Helicobacter pylori infection: Past, present and future
V Papastergiou, SD Georgopoulos… - World journal of …, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is a major human pathogen associated with significant
morbidity and mortality. However, after decades of efforts, treatment of H. pylori remains a …
morbidity and mortality. However, after decades of efforts, treatment of H. pylori remains a …
Treatment of Helicobacter pylori
K Wolle, P Malfertheiner - Best Practice & Research Clinical …, 2007 - Elsevier
Triple therapy, consisting of two antibiotics, clarithomycin and amoxicillin or metronidazole in
combination with a proton pump inhibitor (PPI) has become the first-line option for infection …
combination with a proton pump inhibitor (PPI) has become the first-line option for infection …
The status and progress of first-line treatment against Helicobacter pylori infection: a review
C Liu, Y Wang, J Shi, C Zhang, J Nie… - Therapeutic …, 2021 - journals.sagepub.com
Helicobacter pylori (HP) is a major causative agent of chronic gastritis and peptic ulcer. HP
is also engaged in the development of gastric cancer and gastric mucosa-associated …
is also engaged in the development of gastric cancer and gastric mucosa-associated …
Optimal therapy for Helicobacter pylori infections
E Rimbara, LA Fischbach, DY Graham - … reviews Gastroenterology & …, 2011 - nature.com
Although Helicobacter pylori infection is both a common and a serious bacterial infection,
antimicrobial therapies have rarely been optimized, are prescribed empirically, and provide …
antimicrobial therapies have rarely been optimized, are prescribed empirically, and provide …
[HTML][HTML] Helicobacter pylori therapy: Present and future
Helicobacter pylori (H. pylori) plays a crucial role in the pathogenesis of chronic active
gastritis, peptic ulcer and gastric mucosa-associated lymphoid tissue-lymphoma, and is also …
gastritis, peptic ulcer and gastric mucosa-associated lymphoid tissue-lymphoma, and is also …
Current options for the treatment of Helicobacter pylori
SD Georgopoulos, V Papastergiou… - Expert opinion on …, 2013 - Taylor & Francis
Indroduction: Treatment of Helicobacter pylori (H. pylori) infection is crucial for prevalent
disease's management, including gastritis, peptic ulcer and gastric cancer, whereas novel …
disease's management, including gastritis, peptic ulcer and gastric cancer, whereas novel …
Treatment of Helicobacter pylori
BJ Egan, M Katicic, HJ O'connor, CA O'Morain - Helicobacter, 2007 - Wiley Online Library
Since the discovery of Helicobacter pylori in the early 1980s many treatment regimes have
been developed to effectively treat this infection. International guidelines have allowed …
been developed to effectively treat this infection. International guidelines have allowed …